These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383 [TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study. Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838 [TBL] [Abstract][Full Text] [Related]
5. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR Oncology; 2012; 83(5):292-9. PubMed ID: 22964877 [TBL] [Abstract][Full Text] [Related]
6. Prognostication in advanced cancer: a study examining an inflammation-based score. Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417 [TBL] [Abstract][Full Text] [Related]
7. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233 [TBL] [Abstract][Full Text] [Related]
10. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of the role of inflammation in renal cancer. Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628 [TBL] [Abstract][Full Text] [Related]
12. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ishizuka M; Nagata H; Takagi K; Kubota K Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907 [TBL] [Abstract][Full Text] [Related]
13. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer. Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329 [TBL] [Abstract][Full Text] [Related]
14. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma. Farhan-Alanie OM; McMahon J; McMillan DC Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Neal CP; Mann CD; Sutton CD; Garcea G; Ong SL; Steward WP; Dennison AR; Berry DP Eur J Cancer; 2009 Jan; 45(1):56-64. PubMed ID: 18848775 [TBL] [Abstract][Full Text] [Related]
17. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]